Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - celiprololi hydrochloridum - comprimés pelliculés - celiprololi hydrochloridum 200 mg, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, e 171, hypromellosum, macrogolum 400, macrogolum 6000, pro compresso obducto corresp. natrium 65 µg. - betablocker - synthetika

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - chlorhydrate de céliprolol 200 mg - comprimé pelliculé - 200 mg - chlorhydrate de céliprolol 200 mg - celiprolol

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - chlorhydrate de céliprolol 400 mg - comprimé pelliculé - 400 mg - chlorhydrate de céliprolol 400 mg - celiprolol

Union européenne - français - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).

Union européenne - français - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Union européenne - français - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabète sucré, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Union européenne - français - EMA (European Medicines Agency)

novartis europharm limited - la vildagliptine, la metformine chlorhydrate de - diabète sucré, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).

Canada - français - Health Canada

pendopharm division of pharmascience inc - chlorhydrate d'amantadine - capsule - 100mg - chlorhydrate d'amantadine 100mg - adamantanes

Canada - français - Health Canada

pendopharm division of pharmascience inc - chlorhydrate d'amantadine - sirop - 50mg - chlorhydrate d'amantadine 50mg - adamantanes

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unither pharmaceuticals s.a. - chlorhydrate d'ambroxol 6 mg/ml - solution buvable - 30 mg/5 ml - chlorhydrate d'ambroxol 6 mg/ml - ambroxol